Symbol:
Sltm
Name:
SAFB-like, transcription modulator
RGD ID:
1307526
Description:
Predicted to enable sequence-specific DNA binding activity. Predicted to be involved in regulation of mRNA processing and regulation of transcription by RNA polymerase II. Predicted to be located in nuclear body. Predicted to be active in nucleus. Orthologous to human SLTM (SAFB like transcription modulator); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,5-hexanedione; acrylamide.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC315792; RGD1307526; SAFB-like transcription modulator; similar to modulator of estrogen induced transcription
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 80,096,555 - 80,142,668 (+) NCBI GRCr8 mRatBN7.2 8 71,215,995 - 71,261,821 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 71,216,612 - 71,261,825 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 8 76,977,698 - 77,022,847 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 76,977,822 - 77,022,837 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 76,059,815 - 76,105,645 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 75,020,876 - 75,066,611 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 75,079,798 - 75,085,656 (+) NCBI Celera 8 70,467,318 - 70,512,465 (-) NCBI Celera Cytogenetic Map 8 q24 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Sltm Rat (1->4)-beta-D-glucan multiple interactions ISO Sltm (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLTM mRNA CTD PMID:36331819 Sltm Rat 1,2-dimethylhydrazine multiple interactions ISO Sltm (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SLTM mRNA CTD PMID:22206623 Sltm Rat 1,2-dimethylhydrazine affects expression ISO Sltm (Mus musculus) 6480464 1 and 2-Dimethylhydrazine affects the expression of SLTM mRNA CTD PMID:22206623 Sltm Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Sltm (Mus musculus) 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SLTM promoter] CTD PMID:19654925 Sltm Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLTM mRNA CTD PMID:34747641 Sltm Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Sltm (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLTM mRNA CTD PMID:21570461 and PMID:26377647 Sltm Rat 2,5-hexanedione increases expression EXP 6480464 2 and 5-hexanedione results in increased expression of SLTM mRNA CTD PMID:22952946 Sltm Rat 3,4-methylenedioxymethamphetamine decreases expression ISO Sltm (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of SLTM mRNA CTD PMID:26251327 Sltm Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO SLTM (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLTM mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SLTM mRNA CTD PMID:28628672 Sltm Rat 4,4'-sulfonyldiphenol multiple interactions ISO SLTM (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SLTM mRNA CTD PMID:28628672 Sltm Rat 4,4'-sulfonyldiphenol increases expression ISO Sltm (Mus musculus) 6480464 bisphenol S results in increased expression of SLTM mRNA CTD PMID:39298647 Sltm Rat acrolein multiple interactions ISO SLTM (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLTM mRNA more ... CTD PMID:32699268 and PMID:32845096 Sltm Rat acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of SLTM mRNA CTD PMID:28959563 Sltm Rat aflatoxin B1 increases expression ISO Sltm (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of SLTM mRNA CTD PMID:19770486 Sltm Rat aflatoxin B1 increases methylation ISO SLTM (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of SLTM intron CTD PMID:30157460 Sltm Rat alpha-pinene multiple interactions ISO SLTM (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLTM mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SLTM mRNA CTD PMID:32699268 Sltm Rat arsenite(3-) increases expression ISO Sltm (Mus musculus) 6480464 arsenite results in increased expression of SLTM protein CTD PMID:37955338 Sltm Rat benzene decreases expression ISO Sltm (Mus musculus) 6480464 Benzene results in decreased expression of SLTM mRNA CTD PMID:20018183 Sltm Rat benzo[a]pyrene multiple interactions ISO Sltm (Mus musculus) 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to SLTM promoter] CTD PMID:19654925 Sltm Rat benzo[a]pyrene increases expression ISO Sltm (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SLTM mRNA CTD PMID:19770486 and PMID:22228805 Sltm Rat benzo[a]pyrene diol epoxide I decreases expression ISO SLTM (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 Sltm Rat benzo[e]pyrene increases methylation ISO SLTM (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of SLTM intron CTD PMID:30157460 Sltm Rat bis(2-ethylhexyl) phthalate decreases expression ISO Sltm (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of SLTM mRNA CTD PMID:33754040 Sltm Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLTM mRNA CTD PMID:25181051 Sltm Rat bisphenol A decreases methylation ISO SLTM (Homo sapiens) 6480464 bisphenol A results in decreased methylation of SLTM gene CTD PMID:31601247 Sltm Rat bisphenol A increases expression ISO SLTM (Homo sapiens) 6480464 bisphenol A results in increased expression of SLTM mRNA and bisphenol A results in increased expression of SLTM protein CTD PMID:33670352 and PMID:34186270 Sltm Rat bisphenol A decreases expression ISO Sltm (Mus musculus) 6480464 bisphenol A results in decreased expression of SLTM mRNA CTD PMID:32156529 and PMID:33221593 Sltm Rat bisphenol A multiple interactions ISO SLTM (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLTM mRNA CTD PMID:28628672 Sltm Rat Bisphenol B increases expression ISO SLTM (Homo sapiens) 6480464 bisphenol B results in increased expression of SLTM protein CTD PMID:34186270 Sltm Rat bleomycin A5 decreases expression ISO SLTM (Homo sapiens) 6480464 bleomycetin results in decreased expression of SLTM mRNA CTD PMID:21040473 Sltm Rat butanal decreases expression ISO SLTM (Homo sapiens) 6480464 butyraldehyde results in decreased expression of SLTM mRNA CTD PMID:26079696 Sltm Rat cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SLTM mRNA CTD PMID:33453195 Sltm Rat cadmium dichloride increases expression ISO SLTM (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of SLTM mRNA CTD PMID:26472689 Sltm Rat caffeine decreases phosphorylation ISO SLTM (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of SLTM protein CTD PMID:35688186 Sltm Rat carnosic acid decreases expression ISO Sltm (Mus musculus) 6480464 salvin results in decreased expression of SLTM protein CTD PMID:35926579 Sltm Rat celastrol decreases expression ISO SLTM (Homo sapiens) 6480464 celastrol results in decreased expression of SLTM mRNA CTD PMID:17010675 Sltm Rat chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of SLTM mRNA CTD PMID:23125180 Sltm Rat choline multiple interactions ISO Sltm (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLTM gene CTD PMID:20938992 Sltm Rat coumarin decreases phosphorylation ISO SLTM (Homo sapiens) 6480464 coumarin results in decreased phosphorylation of SLTM protein CTD PMID:35688186 Sltm Rat dexamethasone multiple interactions ISO SLTM (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLTM mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SLTM mRNA CTD PMID:28628672 Sltm Rat diazinon increases expression EXP 6480464 Diazinon results in increased expression of SLTM mRNA CTD PMID:29108742 Sltm Rat Dibutyl phosphate affects expression ISO SLTM (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of SLTM mRNA CTD PMID:37042841 Sltm Rat dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SLTM mRNA CTD PMID:24893172 Sltm Rat dibutyl phthalate decreases expression ISO Sltm (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of SLTM mRNA CTD PMID:21266533 Sltm Rat enzyme inhibitor multiple interactions ISO SLTM (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SLTM protein CTD PMID:23301498 Sltm Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of SLTM mRNA CTD PMID:24136188 Sltm Rat folic acid multiple interactions ISO Sltm (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 Sltm Rat FR900359 affects phosphorylation ISO SLTM (Homo sapiens) 6480464 FR900359 affects the phosphorylation of SLTM protein CTD PMID:37730182 Sltm Rat gedunin decreases expression ISO SLTM (Homo sapiens) 6480464 gedunin results in decreased expression of SLTM mRNA CTD PMID:17010675 Sltm Rat indometacin multiple interactions ISO SLTM (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLTM mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SLTM mRNA CTD PMID:28628672 Sltm Rat ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of SLTM mRNA CTD PMID:20080153 Sltm Rat L-methionine multiple interactions ISO Sltm (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLTM gene CTD PMID:20938992 Sltm Rat methapyrilene increases methylation ISO SLTM (Homo sapiens) 6480464 Methapyrilene results in increased methylation of SLTM intron CTD PMID:30157460 Sltm Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of SLTM gene CTD PMID:35440735 Sltm Rat nefazodone increases expression EXP 6480464 nefazodone results in increased expression of SLTM mRNA CTD PMID:24136188 Sltm Rat oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of SLTM mRNA CTD PMID:25729387 Sltm Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLTM mRNA CTD PMID:25729387 Sltm Rat ozone multiple interactions ISO SLTM (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLTM mRNA more ... CTD PMID:32699268 and PMID:32845096 Sltm Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Sltm (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLTM mRNA CTD PMID:36331819 Sltm Rat phenobarbital decreases expression ISO Sltm (Mus musculus) 6480464 Phenobarbital results in decreased expression of SLTM mRNA CTD PMID:23091169 Sltm Rat pioglitazone multiple interactions ISO SLTM (Homo sapiens) 6480464 pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA] CTD PMID:20847119 Sltm Rat SB 431542 multiple interactions ISO SLTM (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SLTM protein CTD PMID:37664457 Sltm Rat sodium arsenite decreases expression ISO SLTM (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SLTM mRNA CTD PMID:29301061 Sltm Rat sodium arsenite decreases expression ISO Sltm (Mus musculus) 6480464 sodium arsenite results in decreased expression of SLTM mRNA CTD PMID:36209798 Sltm Rat sodium arsenite increases expression ISO SLTM (Homo sapiens) 6480464 sodium arsenite results in increased expression of SLTM mRNA CTD PMID:38568856 Sltm Rat succimer multiple interactions ISO Sltm (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLTM mRNA CTD PMID:21641980 Sltm Rat sunitinib increases expression ISO SLTM (Homo sapiens) 6480464 Sunitinib results in increased expression of SLTM mRNA CTD PMID:31533062 Sltm Rat tert-butyl hydroperoxide multiple interactions ISO SLTM (Homo sapiens) 6480464 [Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of SLTM mRNA more ... CTD PMID:20847119 Sltm Rat tert-butyl hydroperoxide increases expression ISO SLTM (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of SLTM mRNA CTD PMID:20847119 Sltm Rat titanium dioxide decreases methylation ISO SLTM (Homo sapiens) 6480464 titanium dioxide results in decreased methylation of SLTM promoter CTD PMID:34973136 Sltm Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLTM mRNA CTD PMID:25729387 Sltm Rat triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of SLTM mRNA CTD PMID:30589522 Sltm Rat triphenyl phosphate affects expression ISO SLTM (Homo sapiens) 6480464 triphenyl phosphate affects the expression of SLTM mRNA CTD PMID:37042841 Sltm Rat troglitazone multiple interactions ISO SLTM (Homo sapiens) 6480464 [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of SLTM mRNA and troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA] CTD PMID:20847119 Sltm Rat tungsten decreases expression ISO Sltm (Mus musculus) 6480464 Tungsten results in decreased expression of SLTM mRNA CTD PMID:30912803 Sltm Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SLTM mRNA CTD PMID:20566332
(1->4)-beta-D-glucan (ISO) 1,2-dimethylhydrazine (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,5-hexanedione (EXP) 3,4-methylenedioxymethamphetamine (ISO) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-sulfonyldiphenol (ISO) acrolein (ISO) acrylamide (EXP) aflatoxin B1 (ISO) alpha-pinene (ISO) arsenite(3-) (ISO) benzene (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) benzo[e]pyrene (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) Bisphenol B (ISO) bleomycin A5 (ISO) butanal (ISO) cadmium dichloride (EXP,ISO) caffeine (ISO) carnosic acid (ISO) celastrol (ISO) chloroprene (EXP) choline (ISO) coumarin (ISO) dexamethasone (ISO) diazinon (EXP) Dibutyl phosphate (ISO) dibutyl phthalate (EXP,ISO) enzyme inhibitor (ISO) flutamide (EXP) folic acid (ISO) FR900359 (ISO) gedunin (ISO) indometacin (ISO) ketamine (EXP) L-methionine (ISO) methapyrilene (ISO) methoxychlor (EXP) nefazodone (EXP) oxaliplatin (EXP) ozone (ISO) perfluorooctane-1-sulfonic acid (ISO) phenobarbital (ISO) pioglitazone (ISO) SB 431542 (ISO) sodium arsenite (ISO) succimer (ISO) sunitinib (ISO) tert-butyl hydroperoxide (ISO) titanium dioxide (ISO) topotecan (EXP) triphenyl phosphate (EXP,ISO) troglitazone (ISO) tungsten (ISO) vinclozolin (EXP)
Sltm Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 80,096,555 - 80,142,668 (+) NCBI GRCr8 mRatBN7.2 8 71,215,995 - 71,261,821 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 71,216,612 - 71,261,825 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 8 76,977,698 - 77,022,847 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 76,977,822 - 77,022,837 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 76,059,815 - 76,105,645 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 75,020,876 - 75,066,611 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 75,079,798 - 75,085,656 (+) NCBI Celera 8 70,467,318 - 70,512,465 (-) NCBI Celera Cytogenetic Map 8 q24 NCBI
SLTM Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 15 58,879,050 - 58,933,679 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 15 58,879,050 - 58,933,679 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 15 59,171,249 - 59,225,878 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 15 56,958,536 - 57,013,144 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 15 36,059,189 - 36,113,796 (-) NCBI Celera Cytogenetic Map 15 q22.1 NCBI HuRef 15 35,994,164 - 36,048,861 (-) NCBI HuRef CHM1_1 15 59,289,165 - 59,343,802 (-) NCBI CHM1_1 T2T-CHM13v2.0 15 56,681,092 - 56,735,731 (-) NCBI T2T-CHM13v2.0
Sltm Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 9 70,449,717 - 70,499,519 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 9 70,450,036 - 70,499,516 (+) Ensembl GRCm39 Ensembl GRCm38 9 70,542,177 - 70,592,237 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 9 70,542,754 - 70,592,234 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 9 70,390,585 - 70,440,039 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 9 70,341,942 - 70,391,396 (+) NCBI MGSCv36 mm8 Celera 9 67,759,529 - 67,808,982 (+) NCBI Celera Cytogenetic Map 9 D NCBI cM Map 9 39.53 NCBI
Sltm Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955450 15,691,463 - 15,736,709 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955450 15,691,472 - 15,748,123 (+) NCBI ChiLan1.0 ChiLan1.0
SLTM Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 16 48,143,255 - 48,197,766 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 15 52,326,109 - 52,381,526 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 15 37,848,629 - 37,903,221 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 15 56,157,515 - 56,211,801 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 15 56,158,460 - 56,211,695 (-) Ensembl panpan1.1 panPan2
SLTM Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 30 23,858,626 - 23,902,042 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 30 23,859,194 - 23,902,009 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 30 23,832,406 - 23,875,850 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 30 24,027,005 - 24,070,471 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 30 24,027,378 - 24,070,477 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 30 23,950,495 - 23,993,912 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 30 24,035,414 - 24,078,899 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 30 24,178,984 - 24,222,422 (-) NCBI UU_Cfam_GSD_1.0
Sltm Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024408640 102,190,074 - 102,234,347 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936471 20,039,081 - 20,081,721 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936471 20,038,137 - 20,082,410 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
SLTM Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 1 113,084,008 - 113,136,599 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 1 113,085,095 - 113,140,604 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 1 125,132,697 - 125,167,732 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
SLTM Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 26 24,583,671 - 24,639,455 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 26 24,583,699 - 24,642,460 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666048 116,681,827 - 116,738,424 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Sltm
.
1298065 Scl16 Serum cholesterol level QTL 16 3.8 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 8 30856404 75856404 Rat 1554321 Bmd3 Bone mineral density QTL 3 7.9 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 8 40952565 123900184 Rat 1578769 Uae31 Urinary albumin excretion QTL 31 3.3 0.001 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 30848154 101699754 Rat 1298079 Activ2 Activity QTL 2 9.5 0.000001 voluntary movement trait (VT:0003491) rearing measurement (CMO:0001515) 8 41866876 86866876 Rat 70161 Bp62 Blood pressure QTL 62 2.9 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 42692684 90165460 Rat 1578765 Klgr1 Kidney lesion grade QTL 1 3.3 0.0001 kidney morphology trait (VT:0002135) organ lesion measurement (CMO:0000677) 8 30848154 101699754 Rat 1582222 Epfw2 Epididymal fat weight QTL 2 3.2 0.0005 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 8 31737729 76737729 Rat 61464 Niddm11 Non-insulin dependent diabetes mellitus QTL 11 3.1 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 8 35582032 80582032 Rat 4889938 Bss89 Bone structure and strength QTL 89 3.8 tibia size trait (VT:0100001) tibia cortical bone volume (CMO:0001725) 8 50095249 82460899 Rat 1578755 Pur5 Proteinuria QTL 5 3.3 0.0001 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 8 30848154 101699754 Rat 1300146 Rf17 Renal function QTL 17 2.9 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 8 28242912 73242912 Rat 8662823 Vetf5 Vascular elastic tissue fragility QTL 5 1.9 artery integrity trait (VT:0010639) patent ductus arteriosus score (CMO:0002566) 8 28242912 99525068 Rat 2313088 Bss75 Bone structure and strength QTL 75 3.1 0.0001 body length (VT:0001256) body length, nose to rump (CMO:0000079) 8 30848154 82460899 Rat 631210 Bw3 Body weight QTL3 5.9 mesenteric fat pad mass (VT:0010427) mesenteric fat pad weight to body weight ratio (CMO:0000654) 8 69349194 112783834 Rat 1358896 Bp262 Blood pressure QTL 262 2.89 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 27205715 99103503 Rat 731182 Uae24 Urinary albumin excretion QTL 24 6.4 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 19331152 93965294 Rat 737824 Hcar10 Hepatocarcinoma resistance QTL 10 2.9 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 8 40713066 82925667 Rat 1331769 Rf39 Renal function QTL 39 3.871 urine output (VT:0003620) timed urine volume (CMO:0000260) 8 41866876 75097878 Rat 61358 Bp39 Blood pressure QTL 39 2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 35551938 80551938 Rat 1358906 Bp253 Blood pressure QTL 253 4 0.0004 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 40713066 93965294 Rat 1358907 Cm40 Cardiac mass QTL 40 1.89 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 27205715 99103503 Rat 70197 BpQTLcluster8 Blood pressure QTL cluster 8 3.482 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 46531639 119088626 Rat 2316950 Scl66 Serum cholesterol level QTL 66 4.1 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 8 30848259 105647037 Rat 1582254 Kidm31 Kidney mass QTL 31 3 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 8 54237644 85365202 Rat 10402857 Bp380 Blood pressure QTL 380 0.95 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 53968765 98968765 Rat 1358892 Kidm26 Kidney mass QTL 26 3.69 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 8 27205715 99103503 Rat 5684973 Bss100 Bone structure and strength QTL 100 4.7 tibia area (VT:1000281) tibia area measurement (CMO:0001382) 8 50095249 82460899 Rat 1582243 Bw66 Body weight QTL 66 3.4 0.0048 body mass (VT:0001259) body weight (CMO:0000012) 8 54237644 85365202 Rat 2313057 Bss76 Bone structure and strength QTL 76 3 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 8 30848154 82460899 Rat 12879878 Bw183 Body weight QTL 183 0.001 body mass (VT:0001259) body weight (CMO:0000012) 8 43296169 98968765 Rat 1300177 Cm2 Cardiac mass QTL 2 3.65 heart mass (VT:0007028) heart weight (CMO:0000017) 8 54259986 100382532 Rat 1549908 Neudeg1 Neurodegradation QTL 1 5.5 0 nervous system integrity trait (VT:0010566) logarithm of the ratio of the lesioned side motor neuron count to contralateral side motor neuron count (CMO:0001986) 8 30188867 94457446 Rat 12879879 Cm99 Cardiac mass QTL 99 0.001 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 43296169 98968765 Rat 2313067 Bss77 Bone structure and strength QTL 77 3.1 0.0001 tibia size trait (VT:0100001) tibia midshaft endosteal cross-sectional area (CMO:0001716) 8 30848154 82460899 Rat 12879880 Cm100 Cardiac mass QTL 100 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 8 43296169 98968765 Rat 12879881 Cm101 Cardiac mass QTL 101 0.001 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 8 43296169 98968765 Rat 12879882 Am8 Aortic mass QTL 8 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 8 43296169 98968765 Rat 12879883 Kidm65 Kidney mass QTL 65 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 8 43296169 98968765 Rat 1358912 Bw51 Body weight QTL 51 2.95 body mass (VT:0001259) body weight (CMO:0000012) 8 51351728 107062046 Rat 1300171 Bp184 Blood pressure QTL 184 3.66 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 8 70513503 118219066 Rat 2313086 Bss60 Bone structure and strength QTL 60 4.1 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 8 50095249 82460899 Rat 2303171 Bp331 Blood pressure QTL 331 5.57 0.005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 61290298 119084929 Rat 2293697 Bmd39 Bone mineral density QTL 39 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 8 54043744 98968765 Rat 1331837 Bw23 Body weight QTL 23 4.19 0.00007 body mass (VT:0001259) body weight (CMO:0000012) 8 46531722 99083736 Rat 1331838 Niddm61 Non-insulin dependent diabetes mellitus QTL 61 3.53 0.0004 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 8 36469535 99083736 Rat 631650 Stl6 Serum triglyceride level QTL 6 4 0.0019 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 8 10378157 112202585 Rat 631653 Bp125 Blood pressure QTL 125 3.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 66142385 111142385 Rat 1581557 Eae16 Experimental allergic encephalomyelitis QTL 16 3.8 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 8 8462195 110921472 Rat 631271 Lecl1 Lens clarity QTL 1 0.001 lens clarity trait (VT:0001304) age of onset/diagnosis of cataract (CMO:0001584) 8 18984168 84531599 Rat 2303570 Gluco48 Glucose level QTL 48 2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 8 49805831 94805831 Rat 2313046 Bss78 Bone structure and strength QTL 78 3.5 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 8 30848154 82460899 Rat 2301402 Bp316 Blood pressure QTL 316 0.005 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 53968765 98968765 Rat 631664 Hcar3 Hepatocarcinoma resistance QTL 3 2.9 0.0005 liver integrity trait (VT:0010547) volume of individual liver tumorous lesion (CMO:0001078) 8 54237644 99103503 Rat
RH143549
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 71,250,055 - 71,251,134 (+) MAPPER mRatBN7.2 Rnor_6.0 8 77,011,084 - 77,012,162 NCBI Rnor6.0 Rnor_5.0 8 76,070,500 - 76,071,578 UniSTS Rnor5.0 RGSC_v3.4 8 75,054,847 - 75,055,925 UniSTS RGSC3.4 Celera 8 70,478,004 - 70,479,082 UniSTS RH 3.4 Map 2 1191.69 UniSTS Cytogenetic Map 8 q24 UniSTS
D11Bhm134
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 71,225,634 - 71,226,179 (+) MAPPER mRatBN7.2 Rnor_6.0 8 76,986,663 - 76,987,207 NCBI Rnor6.0 Rnor_5.0 8 76,095,455 - 76,095,999 UniSTS Rnor5.0 RGSC_v3.4 8 75,029,720 - 75,030,264 UniSTS RGSC3.4 Celera 8 70,502,960 - 70,503,504 UniSTS Cytogenetic Map 8 q24 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000090268 ⟹ ENSRNOP00000074807
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 71,216,813 - 71,261,796 (+) Ensembl Rnor_6.0 Ensembl 8 76,977,822 - 77,022,837 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000113725 ⟹ ENSRNOP00000084773
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 71,216,612 - 71,261,825 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000117345 ⟹ ENSRNOP00000089853
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 71,216,813 - 71,261,796 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000118420 ⟹ ENSRNOP00000087086
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 71,216,813 - 71,261,796 (+) Ensembl
RefSeq Acc Id:
XM_056984525 ⟹ XP_056840505
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 80,096,555 - 80,142,668 (+) NCBI mRatBN7.2 8 71,216,075 - 71,261,821 (+) NCBI
RefSeq Acc Id:
XM_056984526 ⟹ XP_056840506
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 80,096,555 - 80,142,668 (+) NCBI mRatBN7.2 8 71,216,079 - 71,261,821 (+) NCBI
RefSeq Acc Id:
XM_056984527 ⟹ XP_056840507
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 80,096,555 - 80,142,668 (+) NCBI mRatBN7.2 8 71,216,075 - 71,261,821 (+) NCBI
RefSeq Acc Id:
XM_056984528 ⟹ XP_056840508
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 80,096,555 - 80,142,668 (+) NCBI mRatBN7.2 8 71,216,626 - 71,261,821 (+) NCBI
RefSeq Acc Id:
XM_056984529 ⟹ XP_056840509
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 80,096,555 - 80,142,668 (+) NCBI mRatBN7.2 8 71,216,075 - 71,261,821 (+) NCBI
RefSeq Acc Id:
XM_056984530 ⟹ XP_056840510
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 80,096,555 - 80,142,668 (+) NCBI mRatBN7.2 8 71,216,076 - 71,261,821 (+) NCBI
RefSeq Acc Id:
XM_056984531 ⟹ XP_056840511
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 80,096,555 - 80,136,805 (+) NCBI mRatBN7.2 8 71,216,005 - 71,255,948 (+) NCBI
RefSeq Acc Id:
XM_056984532 ⟹ XP_056840512
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 80,096,555 - 80,136,809 (+) NCBI mRatBN7.2 8 71,215,995 - 71,255,952 (+) NCBI
RefSeq Acc Id:
XM_063266421 ⟹ XP_063122491
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 80,096,555 - 80,142,668 (+) NCBI
RefSeq Acc Id:
XM_063266422 ⟹ XP_063122492
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 80,096,555 - 80,142,668 (+) NCBI
RefSeq Acc Id:
XM_063266423 ⟹ XP_063122493
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 80,096,555 - 80,136,993 (+) NCBI
Ensembl Acc Id:
ENSRNOP00000074807 ⟸ ENSRNOT00000090268
Ensembl Acc Id:
ENSRNOP00000084773 ⟸ ENSRNOT00000113725
Ensembl Acc Id:
ENSRNOP00000087086 ⟸ ENSRNOT00000118420
Ensembl Acc Id:
ENSRNOP00000089853 ⟸ ENSRNOT00000117345
RefSeq Acc Id:
XP_056840512 ⟸ XM_056984532
- Peptide Label:
isoform X10
RefSeq Acc Id:
XP_056840511 ⟸ XM_056984531
- Peptide Label:
isoform X9
RefSeq Acc Id:
XP_056840505 ⟸ XM_056984525
- Peptide Label:
isoform X1
- UniProtKB:
A0A8I6A3K4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_056840507 ⟸ XM_056984527
- Peptide Label:
isoform X3
- UniProtKB:
A0A8I6A3K4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_056840509 ⟸ XM_056984529
- Peptide Label:
isoform X5
- UniProtKB:
A6KES8 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_056840510 ⟸ XM_056984530
- Peptide Label:
isoform X7
- UniProtKB:
A6KES8 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_056840506 ⟸ XM_056984526
- Peptide Label:
isoform X2
RefSeq Acc Id:
XP_056840508 ⟸ XM_056984528
- Peptide Label:
isoform X4
RefSeq Acc Id:
XP_063122491 ⟸ XM_063266421
- Peptide Label:
isoform X6
- UniProtKB:
A0A8I6AB75 (UniProtKB/TrEMBL), A6KES8 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063122492 ⟸ XM_063266422
- Peptide Label:
isoform X8
- UniProtKB:
A6KES8 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063122493 ⟸ XM_063266423
- Peptide Label:
isoform X10
RGD ID: 13696107 Promoter ID: EPDNEW_R6630 Type: initiation region Name: Sltm_1 Description: SAFB-like, transcription modulator SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 8 76,977,826 - 76,977,886 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2013-11-22
Sltm
SAFB-like, transcription modulator
RGD1307526
similar to modulator of estrogen induced transcription
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2005-12-06
RGD1307526
similar to modulator of estrogen induced transcription
RGD1307526_predicted
similar to modulator of estrogen induced transcription (predicted)
Symbol and Name updated
1559027 APPROVED
2005-01-20
RGD1307526_predicted
similar to modulator of estrogen induced transcription (predicted)
LOC315792_predicted
Symbol and Name status set to approved
1331353 APPROVED
2005-01-12
LOC315792_predicted
similar to modulator of estrogen induced transcription (predicted)
Symbol and Name status set to provisional
70820 PROVISIONAL
